Jiangsu Nhwa Pharmaceutical Co., Ltd.
12
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
17%
2 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
A Study of NH280105 in Healthy Adult Participants
Role: lead
Multiple Ascending Dose Study of NH102 in Healthy Subjects
Role: lead
A Phase II Study to Evaluate NH102 for Depression
Role: lead
Single Ascending Dose Study of NH102 in Healthy Subjects
Role: lead
Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China
Role: collaborator
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
Role: lead
Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
Role: collaborator
A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients
Role: lead
Combined Use of Etomidate and Propofol in Painless Gastroscopy.
Role: lead
Etomidate Emulsion for Sedation in Patients Scheduled for Upper Gastrointestinal (GI) Endoscopy
Role: lead
A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression
Role: collaborator
A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects
Role: collaborator
All 12 trials loaded